| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 104111-21-9 | Cholestano[3,4-c][1,2,5]oxadiazole(9CI); 4H-Cyclopenta[7,8]phenanthro[1,2-c][1,2,5]oxadiazole,cholestano[3,4-c][1,2,5]oxadiazole deriv.; 4H-Cyclopenta[7,8]phenanthro[1,2-c][1,2,5]oxadiazole,8-(1,5-dimethylhexyl)-5,5a,5b,6,7,7a,8,9,10,10a,10b,11,12,12a-tetradecahydro-5a,7a-dimethyl-,[5aR-[5aa,5bb,7aa,8a(R*),10ab,10ba]]-; [5aR-[5aa,5bb,7aa,8a(R*),10ab,10ba]]-8-(1,5-Dimethylhexyl)-5,5a,5b,6,7,7a,8,9,10,10a,10b,11,12,12a-tetradecahydro-5a,7a-dimethyl-4H-cyclopenta[7,8]phenanthro[1,2-c][1,2,5]oxadiazole |  | C27H44N2O | 詳情 | 供應商 | |
| 232257-97-5 | Heptadecanamide,N-[2-(1H-indol-3-yl)ethyl]-; Margaric acid tryptamide, MAT, N-[2-(3-Indolyl)ethyl]heptadecanamide, N-Heptadecanoyltryptamine |  | C27H44N2O | 詳情 | 供應商 |